WUXI APPTEC
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for s... mall molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
WUXI APPTEC
Industry:
Biotechnology Health Care Medical Device Outsourcing Pharmaceutical
Founded:
2000-12-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.wuxiapptec.com
Total Employee:
10001+
Status:
Active
Contact:
651-675-2000
Total Funding:
1.59 B USD
Technology used in webpage:
SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Domain Not Resolving Global Site Tag Nginx Sitelinks Search Box Amazon
Similar Organizations
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Current Employees Featured
Shuhui Chen Chief Scientific Officer @ WuXi AppTec
Chief Scientific Officer
Peter Tong Chief Operating Officer @ WuXi AppTec
Chief Operating Officer
Ge Li Founder, Chairman and CEO @ WuXi AppTec
Founder, Chairman and CEO
2008-01-01
RJ Fitch Vice President Operations & General Manager @ WuXi AppTec
Vice President Operations & General Manager
2016-01-01
Zhaohui Zhang Senior Vice President of Operations @ WuXi AppTec
Senior Vice President of Operations
Steve Yang Co-CEO @ WuXi AppTec
Co-CEO
Edward Hu Co-CEO @ WuXi AppTec
Co-CEO
2018-08-01
Ellis Chu Chief Financial Officer @ WuXi AppTec
Chief Financial Officer
2019-01-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-03-01 | Oxford Genetics | Oxford Genetics acquired by WuXi AppTec | N/A |
| 2019-05-05 | Pharmapace | Pharmapace acquired by WuXi AppTec | N/A |
| 2017-10-17 | ResearchPoint Global | ResearchPoint Global acquired by WuXi AppTec | N/A |
| 2017-01-19 | HD Biosciences | HD Biosciences acquired by WuXi AppTec | N/A |
| 2016-04-15 | Crelux | Crelux acquired by WuXi AppTec | N/A |
| 2015-01-09 | NextCODE Health | NextCODE Health acquired by WuXi AppTec | 65 M USD |
Investors List
Ping An Bank
Ping An Bank investment in Debt Financing - WuXi AppTec
Warburg Pincus
Warburg Pincus investment in Post-IPO Equity - WuXi AppTec
Eight Roads Ventures
Eight Roads Ventures investment in Series C - WuXi AppTec
Eight Roads Ventures
Eight Roads Ventures investment in Series B - WuXi AppTec
Eight Roads Ventures
Eight Roads Ventures investment in Series A - WuXi AppTec
NewSpring
NewSpring investment in Venture Round - WuXi AppTec
Commerce Health Capital
Commerce Health Capital investment in Venture Round - WuXi AppTec
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-20 | ShouTi | WuXi AppTec investment in Series B - ShouTi | 100 M USD |
| 2021-06-03 | Stemirna | WuXi AppTec investment in Venture Round - Stemirna | 1.2 B CNY |
| 2021-05-28 | MegaRobo | WuXi AppTec investment in Corporate Round - MegaRobo | 65 M USD |
| 2021-05-26 | Engine Biosciences | WuXi AppTec investment in Series A - Engine Biosciences | 43 M USD |
| 2021-05-10 | OakMega | WuXi AppTec investment in Series A - OakMega | N/A |
| 2021-02-22 | AnchorDx | WuXi AppTec investment in Series C - AnchorDx | 40 M USD |
| 2021-02-09 | Drug Farm | WuXi AppTec investment in Series A - Drug Farm | 56 M USD |
| 2020-11-17 | D3 Bio | WuXi AppTec investment in Series A - D3 Bio | 200 M USD |
| 2020-06-11 | JW Therapeutics | WuXi AppTec investment in Series B - JW Therapeutics | 100 M USD |
| 2020-05-26 | Insitro | WuXi AppTec investment in Series B - Insitro | 143 M USD |
Newest Events participated
Participated in BioProcess International West 2017
on 2017-02-27 as sponsor
Official Site Inspections
http://www.wuxiapptec.com Semrush global rank: 819.81 K Semrush visits lastest month: 47.12 K
- Host name: 48.211.129.204
- IP address: 48.211.129.204
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "WuXi AppTec"
WuXi AppTec: Enabling Innovation
WuXi AppTec Recognized as an Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for the Third Consecutive Year. SHANGHAI, March 12, 2025 - WuXi AppTec, a …See details»
WuXi AppTec - Wikipedia
WuXi PharmaTech was founded in December 2000 in Shanghai by organic chemist Ge Li. [1] [2]The company opened chemistry facilities in Tianjin in 2007. In 2008, WuXi PharmaTech …See details»
WuXi AppTec Org Chart + Executive Team - The Official Board
Www.wuxiapptec.com. has 69 executives and 5 subsidiaries - and belongs to Genuity Science +86 215 046 1111; Add an executive. WuXi AppTec (603259) News . Anything missing? We …See details»
WuXi AppTec Company Profile - American …
Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical …See details»
WuXi AppTec - Crunchbase Company Profile & Funding
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to …See details»
WuXi AppTec Co Ltd Company Profile - Overview - GlobalData
Website www.wuxiapptec.com Telephone 86 21 50461111. No of Employees 39,414. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange 603259 (SHA) Revenue (2023) …See details»
Every drug can be made and every disease can be treated - WuXi …
Organization), biology discovery, preclinical testing and clinical research services, advanced therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping …See details»
CEO Message - WuXi AppTec
The collective power of one -– one individual, one organization, one idea, or just one dream – is what the future can, and will be built upon. At WuXi AppTec, we will continue to relentlessly enhance our enabling platform with the most …See details»
Corporate Social Responsibility Report - WuXi AppTec
05 06 Corporate Social Responsibility Report 2018 WuXi AppTec at a Glance Responsibility for Healthcare Industry Responsibility for Environment and Community ...See details»
About WuXi AppTec DMPK - WuXi AppTec DMPK
Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development, and Manufacturing Organization), biology discovery, preclinical testing and clinical …See details»
WuXi AppTec Receives 2022 Global Contract Research, …
SHANGHAI, November 29, 2022 – WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services for the pharmaceutical, biotech and medical …See details»
WuXi AppTe's Changzhou and Taixing API Sites Successfully Pass …
Apr 1, 2025 WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences industry, …See details»
Business Conduct and Ethics - WuXi AppTec
To report a non-compliant issue, please contact InternalAudit@wuxiapptec.com. Research and Development Ethics . WuXi AppTec consistently adheres to bioethical standards across all …See details»
Home | WuXi AppTec
Grâce à une approche unique et innovante, les services intégrés et complets de WuXi AppTec incluent la chimie, CRDMO (Contract Research, Development and Manufacturing …See details»
Corporate Governance - WuXi AppTec
Mar 17, 2024 Tel: 400-820-0985 (Mainland China) 857-413-2800 (U.S.) +86 (21) 2066-3734 (Global)See details»
WuXi AppTec Code of Business Conduct and Ethics
- Reporting mailbox: InternalAudit@wuxiapptec.com ; - Reporting hotline: 86-400-820-6869; or - Ding Talk ："Compliance Report". North America, Europe, Israel and UK: - The head of your …See details»
Unternehmensführung und Ethik | WuXi AppTec
Wenn Sie einen Verstoß gegen die Vorschriften melden möchten, wenden Sie sich bitte an InternalAudit@wuxiapptec.com. Ethische Forschung und Entwicklung . WuXi AppTec hält sich …See details»
Enabling Innovation - WuXi AppTec
Through its unique business models, WuXi AppTec's integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), …See details»
WuXi AppTec – Swiss Biotech
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable global …See details»
WuXi AppTec Q1 2025 Revenue, Profit Resume Double Digit …
The Company’s sustained and steady business growth is the result of our unique, fully integrated Contract Research, Development and Manufacturing Organization (CRDMO) platform. WuXi …See details»